On behalf of the NCRI Chronic Myeloid Leukaemia Working Group, Professor Richard Clark and I have pleasure in inviting you to the next annual one day meeting on CML for Professionals. The details are currently being finalized, but it will be held in the Manchester Conference Centre on Friday May 7th, with a Conference Dinner on the Thursday evening for attendees who will be arriving the night before.

The speakers will be drawn from the UK and Europe and the provisional list of topics includes:

 

• The CML Stem Cell 
• Recent advances in molecular pathogenesis of the myeloproliferative disorders 
• BCR-ABL – how should we monitor CML treatment? 
• Pharmacology of the Tyrosine Kinase Inhibitors 
• The new LeukemiaNet Guidelines on CML management 
• Imatinib – the first nine years experience 
• Can we ever stop Imatinib? – debate 
• The new Tyrosine Kinase Inhibitors
• Tolerance and compliance with CML treatment  

 

Further details and registration forms will be available shortly, but anyone interested is invited to contact marion.mckenna@cmft.nhs.uk or call 0161-276 3360

Guy Lucas, Consultant Haematologist, Manchester Royal Infirmary